Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer
- 1 March 2005
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 47 (3), 385-394
- https://doi.org/10.1016/j.lungcan.2004.08.016
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 2003
- The role of chemotherapy in early non-small-cell lung cancer managementLung Cancer, 2001
- A Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II or IIIa Non–Small-Cell Lung CancerNew England Journal of Medicine, 2000
- Revisions in the International System for Staging Lung CancerChest, 1997
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Surgical Adjuvant Therapy for Stage II and Stage III Adenocarcinoma and Large Cell Undifferentiated CarcinomaChest, 1994
- Adjuvant Chemotherapy With Cyclophosphamide, Doxorubicin, and Cisplatin in Patients With Completely Resected Stage I Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1993
- The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. The Lung Cancer Study Group.Journal of Clinical Oncology, 1988